Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 3 Pulmonary Hypertension”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Not applicableLooking for participantsNCT06388421
What this trial is testing

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and HypoxiaPulmonary HypertensionInterstitial Lung Disease
United Therapeutics 900
Not applicableActive Not RecruitingNCT06714136
What this trial is testing

The Role of miRNA in Group 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
IRCCS Azienda Ospedaliero-Universitaria di Bologna 27
Large-scale testing (Phase 3)Looking for participantsNCT07179380
What this trial is testing

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 344
Large-scale testing (Phase 3)Active Not RecruitingNCT05983250
What this trial is testing

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Who this might be right for
Pulmonary Hypertension
Tenax Therapeutics, Inc. 230
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)Looking for participantsNCT07481981
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Insmed Incorporated 344
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Large-scale testing (Phase 3)Study completedNCT01743001
What this trial is testing

Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 226
Not applicableStudy completedNCT01468545
What this trial is testing

Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 38
Testing effectiveness (Phase 2)Study completedNCT02951429
What this trial is testing

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 177
Post-approval studies (Phase 4)UnknownNCT05716984
What this trial is testing

RhBNP in Type 3 Pulmonary Hypertension

Who this might be right for
Group 3 Pulmonary Hypertension
Shengjing Hospital 72
Not applicableStudy completedNCT05001711
What this trial is testing

Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Aria CV, Inc 18
Large-scale testing (Phase 3)Enrolling By InvitationNCT03683186
What this trial is testing

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 1,000
Not applicableStudy completedNCT07478094
What this trial is testing

Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases
University of Sao Paulo General Hospital 72
Not applicableNot Yet RecruitingNCT07263958
What this trial is testing

Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)

Who this might be right for
Pulmnary HypertensionCOPDPulmonary Hypertension Secondary to Lung Disease and/or Hypoxia
University of Sao Paulo General Hospital 15
Not applicableLooking for participantsNCT07768644
What this trial is testing

Nailfold Capillaroscopy in PH

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Hypertension (World Health Organization Group 3)Chronic Thromboembolic Pulmonary Hypertension
University of Glasgow 60
Large-scale testing (Phase 3)Study completedNCT03904693
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Actelion 187
Large-scale testing (Phase 3)Looking for participantsNCT07288398
What this trial is testing

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 540
Very early researchEnded earlyNCT03135860
What this trial is testing

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

Who this might be right for
COPDPulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon 7
Next Page